- Disease: COVID-19, Influenza, Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Natural History
- Study type descriptors: Retrospective, Multicentre
- Objective: To identify risk factors for severe bronchiolitis in two consecutive respiratory syncytial virus (RSV) seasons (before and after the introduction of nirsevimab) in Southern Italy
- Number of participants enrolled: 1056
- Study enrolling from to
Study Data
- General population
- Infants (<1 year)
- Hospital
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to